Tuberculosis in patientes treated with tumor necrosis factor-alpha antagonists living in an endemic area. Is the risk worthwhile?

Tuberculosis in patientes treated with tumor necrosis factor-alpha antagonists living in an endemic area. Is the risk worthwhile? Adriana Rojas-Villarraga, Carlos Andrés Agudelo, Ricardo Pineda-Tamayo … [et.al] - Bogotá, D. C Instituto Nacional de Salud 2007 - 159-71 ilus.;tbls - Vol. 27, no. 2 (jun. 2007)

Tumor necrosis factor alpha antagonists (TNFA) are biological agents to treat chronic inflammatory and autoimmune diseases. However, their use is associated with an increased rate of tuberculosis, endemic mycoses, and intracellular bacterial infections. S = Biomédica


Tuberculosis
Enfermedades endémicas
Factor de necrosis tumoral alfa


Colombia

Instituto Nacional de Salud

Sede principal

Dirección: Avenida calle 26 No. 51-20 - Zona 6 CAN. Bogotá, D.C.

Código Postal: 111321

Horario de atención: Lunes a Viernes de 8:00 a.m. - 5:00 p.m.

Teléfono conmutador: +57(601) 220 7700

Línea gratuita: +57(601) 018000113400

Línea PQRSD: +57-(601) 324-4576

Línea Anticorrupción: +57-(601) 324-4576

Correo correspondencia: correspondencia@ins.gov.co

Correo PQRSD: contactenos@ins.gov.co

Correo de notificaciones judiciales: procesosjudiciales@ins.gov.co

Correo anticorrupción: denuncias.ciudadano@ins.gov.co
Brigada de emergencias del Instituto Nacional de Salud